 |
|
Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clin Mol Hepatol. 2021;27(1):1-21. Published online 2020 Dec 3 DOI: https://doi.org/10.3350/cmh.2020.0028
|
|
Citations to this article as recorded by
 Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology
Yuanyuan Li, Xiaotian Peng, Guofeng Wang, Bin Zan, Yahang Wang, Juan Zou, Tian Tian, Qian Meng, Rong Shi, Tianming Wang, Jiasheng Wu, Yueming Ma
Journal of Ethnopharmacology.2024; 319: 117060. CrossRef Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis
Miaochan Wang, Yujiao Jin, Aifang Xu
Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(2): e53. CrossRef Autotaxin: A Potential biomarker for primary biliary cholangitis
Yifei Yang, Bingqian Liu, Bo Zang, Qixuan Liu, Chenyang Zhao, Yuan Yao, Bin Liu
Heliyon.2024; 10(1): e23438. CrossRef Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center
Seyed Erfan Mehdi Nejad, Mohammad Heiat, Mohammad Javanbakht, Seyed Moayed Alavian, Mohammad Ali Abyazi Haris
BMC Gastroenterology.2024;[Epub] CrossRef Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
Matteo Biagi, Elisa Bernasconi, Carmela Cursaro, Enrico Ronconi, Filippo Zanni, Pamela Sighinolfi, Pietro Andreone
Exploration of Drug Science.2024; : 1. CrossRef Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study
Zhekang Liu, Yijia Shao, Xinwang Duan, Alessandro Granito
PLOS ONE.2024; 19(2): e0298225. CrossRef Current Perspectives on the Molecular and Clinical Relationships between Primary Biliary Cholangitis and Hepatocellular Carcinoma
Annarosa Floreani, Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences.2024; 25(4): 2194. CrossRef Reasons why women are more likely to develop primary biliary cholangitis
Di Ma, Jiaxuan Ma, Chunmei Zhao, Wenlin Tai
Heliyon.2024; 10(4): e25634. CrossRef Autoimmune hepatitis-primary biliary cholangitis overlap syndrome complicated by various autoimmune diseases: A case report
Yu-Jie Qin, Ting Gao, Xing-Nian Zhou, Ming-Liang Cheng, Hong Li
World Journal of Clinical Cases.2024; 12(6): 1174. CrossRef Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review
Salma Souissi, Sarah Laabidi, Nadia Ben Mustpha, Ines Chelly, Meriem Serghini, Monia Fekih, Asma Laabidi, Jalel Boubaker
Future Science OA.2024;[Epub] CrossRef Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective
Sylvia Drazilova, Tomas Koky, Marian Macej, Martin Janicko, Dagmar Simkova, Ariunzaya Tsedendamba, Slavomira Komarova, Peter Jarcuska
Gastroenterology Insights.2024; 15(2): 419. CrossRef Autoimmune Liver Disease Associated Uveitis: An Extrahepatic Manifestation or a Polyautoimmunity Phenomenon? Case Reports
Laura Zarate-Pinzón, Gabriela Flórez-Esparza, Camilo Andrés Rodríguez-Rodríguez, Luis A. Diez-Bahamón, Germán Mejía-Salgado, Carlos Cifuentes-González, Alejandra de-la-Torre
Ocular Immunology and Inflammation.2024; : 1. CrossRef Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis
Yazhen Zhang, Yujiao Jin, Yuan Liu, Miaochan Wang, Aifang Xu
Clinical Chemistry and Laboratory Medicine (CCLM).2024; 62(8): e193. CrossRef Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis
Jingqin Hu, Yuqiang Mi, Li Wang, Feng Jiang, Ping Li
Clinics and Research in Hepatology and Gastroenterology.2024; 48(7): 102394. CrossRef Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk
Yan Liang, Jie Li, Zhiyu Zhang, Tingwang Jiang, Zaixing Yang
Clinics and Research in Hepatology and Gastroenterology.2024; 48(5): 102321. CrossRef JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Clinical and Molecular Hepatology.2024; 30(2): 166. CrossRef Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy
Isa Seida, Maisam Al Shawaf, Naim Mahroum
Autoimmunity Reviews.2024; : 103541. CrossRef Are Gender Differences Important for Autoimmune Liver Diseases?
Annarosa Floreani, Daniela Gabbia, Sara De Martin
Life.2024; 14(4): 500. CrossRef Targeting NTCP for liver disease treatment: A promising strategy
Xin Tan, Yu Xiang, Jianyou Shi, Lu Chen, Dongke Yu
Journal of Pharmaceutical Analysis.2024; : 100979. CrossRef Comorbidities, mortality and metabolic profile in individuals with primary biliary cholangitis—A Phenome‐Wide‐Association‐Study
Paul‐Henry Koop, Constanze Schwenzer, Jan Clusmann, Mara S. Vell, Julius Jaeger, Wenfang Gui, Christian Trautwein, Alexander Koch, Tony Bruns, Carolin V. Schneider, Kai Markus Schneider
Liver International.2024;[Epub] CrossRef Protective effects and mechanism of Sangyu granule on acetaminophen-induced liver injury in mice
Kexin Xiao, Hongyu Li, Yuening Li, Bo Zhan, Xiaohua Fang, Bingjie Zhao, Xiaofei Zhang, Yumei Wu, Fan Wang, Yanyan Jia
Journal of Ethnopharmacology.2024; 331: 118282. CrossRef Diagnostic value of anti-hexokinase 1 and anti-kelch-like 12 antibodies in primary biliary cholangitis patients
Min Yang, Chao Hu, Jun Huang, Ying Fu, Qi Zhang, Yulan Cheng, Jie Lu, Guiling Li, Jun Zhang
Journal of Laboratory Medicine.2024; 48(3): 129. CrossRef Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis
Qi Wang, Xiaomeng Tang, Wenying Qiao, Lina Sun, Han Shi, Dexi Chen, Bin Xu, Yanmin Liu, Juan Zhao, Chunyang Huang, Ronghua Jin
Microbes and Infection.2024; : 105368. CrossRef Associations between residential volatile organic compound exposures and liver injury markers: The role of biological sex and race
Banrida Wahlang, Hong Gao, Shesh N. Rai, Rachel J. Keith, Craig J. McClain, Sanjay Srivastava, Mathew C. Cave, Aruni Bhatnagar
Environmental Research.2023; 221: 115228. CrossRef Epidemiology and updated management for autoimmune liver disease
Nae-Yun Heo, Haeryoung Kim
Clinical and Molecular Hepatology.2023; 29(1): 194. CrossRef Evalucation of differences in clinical and laboratory parameters in the combination of primary biliary cholangitis and associated diseases
B. A. Abilbekova, A. Zh. Satmetova
Experimental and Clinical Gastroenterology.2023; (8): 70. CrossRef Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies—A Critical Overview
Beata Kasztelan-Szczerbinska, Anna Rycyk-Bojarzynska, Agnieszka Szczerbinska, Halina Cichoz-Lach
Nutrients.2023; 15(3): 760. CrossRef Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation
Huiwen Wang, Jian Zhang, Jinqing Liu, Yongfang Jiang, Lei Fu, Shifang Peng
Frontiers in Molecular Biosciences.2023;[Epub] CrossRef Clinical Characteristics of Patients with Primary Biliary Cholangitis Complicated with Sjogren’s Syndrome
晨阳 赵
Advances in Clinical Medicine.2023; 13(02): 2690. CrossRef Japanese subgroup analysis of GLIMMER: A global Phase IIb study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis
Atsushi Tanaka, Masanori Atsukawa, Keiji Tsuji, Kazuo Notsumata, Akari Suyama, Hiroshi Ito, Sugato Das, Robyn von Maltzahn, Megan M. McLaughlin
Hepatology Research.2023; 53(7): 629. CrossRef Diabetic Mastopathy With an Associated History of Elevated Thyroid Peroxidase (TPO) and Antimitochondrial Antibodies (AMA)
Shreyan A Patel, Saba Naamo, Liping Li, Tatianie Jackson
Cureus.2023;[Epub] CrossRef The impact of recipient and donor gender-match and mismatch on the post-liver transplant outcomes of patients with primary biliary cholangitis
David Uihwan Lee, Reid Ponder, Sarah Sandlow, Ashley Yoo, Ki Jung Lee, Harrison Chou, Gregory Hongyuan Fan, Nathalie Helen Urrunaga
Digestive and Liver Disease.2023; 55(9): 1242. CrossRef Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: A nationwide population‐based study
Jur‐Shan Cheng, Wei‐Ting Chen, Hsin‐Ping Ku, Rong‐Nan Chien, Ming‐Ling Chang
Hepatology Research.2023; 53(9): 866. CrossRef Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019
Kyung-Ah Kim, Hwa Young Choi, Moran Ki, Eun Sun Jang, Sook-Hyang Jeong
Journal of Gastroenterology.2023; 58(7): 682. CrossRef An Unexpected Association of Primary Biliary Cholangitis in a Male Patient With Autosomal Dominant Polycystic Kidney Disease
Patricio A Jaramillo, Sabina Ibrahimli, Javier Castells
Cureus.2023;[Epub] CrossRef Serological markers of rheumatoid arthritis in patients with primary biliary cholangitis and the vice versa: A Tunisian study
Mariam Ghozzi, Amani Mankai, Inssaf Zneidi, Wiem Manoubi, Sarra Melayah, Fatma Mechi, Abdelhalim Trabelsi, Ibtissem Ghedira
Immunobiology.2023; 228(4): 152398. CrossRef Primary Biliary Cholangitis: Promising Emerging Innovative Therapies and Their Impact on GLOBE Scores
Aalam Sohal, Kris V Kowdley
Hepatic Medicine: Evidence and Research.2023; Volume 15: 63. CrossRef Primary biliary cholangitis: Epidemiology, prognosis, and treatment
Juan Trivella, Binu V. John, Cynthia Levy
Hepatology Communications.2023;[Epub] CrossRef Immunological factors in cirrhosis diseases from a bibliometric point of view
Dan Zhang, Bo-Wen Liu, Xiao-Qing Liang, Fu-Quan Liu
World Journal of Gastroenterology.2023; 29(24): 3899. CrossRef Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study
Jiaxi Zhao, Kaixin Li, Xiaoyang Liao, Qian Zhao
Scientific Reports.2023;[Epub] CrossRef Magnetic resonance imaging findings of the lower limb muscles in anti-mitochondrial M2 antibody-positive myositis
Hirotaka Nomiya, Tadanori Hamano, Naoko Takaku, Hirohito Sasaki, Kojiro Usui, Sayaka Sanada, Tomohisa Yamaguchi, Yuki Kitazaki, Yoshinori Endo, Tomoko Kamisawa, Soichi Enomoto, Norimichi Shirafuji, Akiko Matsunaga, Asako Ueno, Masamichi Ikawa, Osamu Yamam
Neuromuscular Disorders.2023; 33(9): 74. CrossRef Primary biliary cholangitis: primary autoimmune disease or primary secretory defect
Annarosa Floreani, Daniela Gabbia, Sara De Martin
Expert Review of Gastroenterology & Hepatology.2023; 17(9): 863. CrossRef Management of adults with Alagille syndrome
Mohammed D. Ayoub, Ahmad A. Bakhsh, Shannon M. Vandriel, Verena Keitel, Binita M. Kamath
Hepatology International.2023; 17(5): 1098. CrossRef Advances in clinical detection methods and nanomaterials for autoimmune liver diseases
Jingjing Chen, Yaqi Zhu, Qingcui Wang, Jinya Ding, Xiaohua Chen
Nano TransMed.2023; 2(2-3): 100003. CrossRef Estrogen receptor alpha‐mediated mitochondrial damage in intrahepatic bile duct epithelial cells leading to the pathogenesis of primary biliary cholangitis
Mengting Liang, Siwen Ye, Rubin Jing, Bukun Zhu, Wenjie Yuan, Xi Chu, Ying Li, Wei Zhang
Environmental Toxicology.2023; 38(12): 2803. CrossRef The feasibility and acceptability of an online mind-body wellness program for patients with primary biliary cholangitis
Makayla Watt, Ashley Hyde, John C Spence, Gail M Wright, Shauna Vander Well, Emily Johnson, Andrew Mason, Magnus McLeod, Puneeta Tandon
Canadian Liver Journal.2023; 6(3): 314. CrossRef Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets
Alina Grama, Alexandra Mititelu, Claudia Sîrbe, Gabriel Benţa, Tudor Lucian Pop
Frontiers in Immunology.2023;[Epub] CrossRef Antimitochondrial antibody associated with liver cirrhosis in patients with primary biliary cholangitis
Yujiao Jin, Miaochan Wang, Yuan Liu, Aifang Xu
Medicine.2023; 102(42): e35617. CrossRef Detection of Lymphadenopathy as a Precursor to Autoimmune Liver Diseases Before Clinical Hepatitis Became Apparent: A Report of Two Cases
Hiroshi Okano, Hiroki Tanaka, Shimpei Matsusaki, Katsumi Mukai, Akira Nishimura, Kana Asakawa, Youichirou Baba, Tetsuya Murata
Cureus.2023;[Epub] CrossRef Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
Hyejung Jang, Nayoung Han, Christine E. Staatz, Jae-Hwan Kwak, In-hwan Baek
Clinics and Research in Hepatology and Gastroenterology.2023; 47(10): 102227. CrossRef Regulation of CD47 expression on CD14+ monocytes by interferon-α in PBC patients
Xi Su, Wenwen Jin, Lizhi Liu, Zifei Zhu, Cunyan Li
Frontiers in Immunology.2023;[Epub] CrossRef Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review
Hong-Jin Chen, Ting-Xiong Huang, Yu-Xi Jiang, Xiong Chen, Ai-Fang Wang
World Journal of Hepatology.2023; 15(12): 1258. CrossRef E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants
Yao Yang, Jinjung Choi, Ying Chen, Pietro Invernizzi, Guoxiang Yang, Weici Zhang, Ti‐hong Shao, Frank Jordan, Natalia S. Nemeria, Ross L. Coppel, William M. Ridgway, Mark Kurth, Aftab A. Ansari, Patrick S.C. Leung, M. Eric Gershwin
Hepatology.2022; 75(2): 266. CrossRef Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid
Weijia Han, Chunyang Huang, Qi Zhang, Shuhui Tao, Xiaomin Hu, Jianguo Xu, Ronglong Jiang, Bin Xu, Yanmin Liu, Jinlin Hou
European Journal of Clinical Investigation.2022;[Epub] CrossRef Working Algorithms and Detection Methods of Autoantibodies in Autoimmune Liver Disease: A Nationwide Study
Guillermo Muñoz-Sánchez, Albert Pérez-Isidro, Iñaki Ortiz de Landazuri, Antonio López-Gómez, Luz Yadira Bravo-Gallego, Milagros Garcia-Ormaechea, Maria Rosa Julià, Odette Viñas, Estíbaliz Ruiz-Ortiz
Diagnostics.2022; 12(3): 697. CrossRef Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature
Ivan Isaia, Giuseppe Natoli, Michele Colaci, Benedetta Stancanelli, Lorenzo Malatino
The American Journal of the Medical Sciences.2022; 364(3): 359. CrossRef Primary Biliary Cholangitis
Andrew R. Scheinberg, Cynthia Levy
Current Treatment Options in Gastroenterology.2022; 20(3): 469. CrossRef Terapias usuales y emergentes en colangitis biliar primaria
Juan Camilo Díaz-Duque, Valeria Palacio-Valencia, Julissa Suárez-Meneses, Jesús Antonio Montaña-López, Eliana Palacio-Sánchez
Hepatología.2022; : 155. CrossRef Hiperbilirrubinemia: visión del patólogo
Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio
Hepatología.2022; : 176. CrossRef Immune-mediated liver injury represented as overlap syndrome after SARS-CoV-2 vaccination
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Sung Hak Lee, Pil Soo Sung
Journal of Hepatology.2022; 77(4): 1209. CrossRef Loperamide induces excessive accumulation of bile acids in the liver of mice with different diets
Zili Lei, Hedong Rong, Yanhong Yang, Siping Yu, Tianle Zhang, Lei Chen, Ya Nie, Qi Song, Qing Hu, Jiao Guo
Toxicology.2022; 477: 153278. CrossRef Endothelin receptor B enhances liver injury and pro-inflammatory responses by increasing G-protein-coupled receptor kinase-2 expression in primary biliary cholangitis
Guoxin Xu, Yanping Gong, Fenying Lu, Bin Wang, Zaixing Yang, Long Chen, Jingyu Min, Cuie Cheng, Tingwang Jiang
Scientific Reports.2022;[Epub] CrossRef Clinical and Pathological Research Progress of Common Autoimmune Liver Diseases
良玉 丁
Advances in Clinical Medicine.2022; 12(10): 8983. CrossRef Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review
Liuting Zeng, Kailin Yang, Tianqing Zhang, Xiaofei Zhu, Wensa Hao, Hua Chen, Jinwen Ge
Journal of Autoimmunity.2022; 133: 102919. CrossRef Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(4): 926. CrossRef Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis
Hong-Li Liu, An-Yin Yang, Qing-Fang Xiong, Yan-Dan Zhong, Du-Xian Liu, Ping Huang, Xiao-Ning Feng, Yu Zhang, Yong-Feng Yang
BMC Gastroenterology.2022;[Epub] CrossRef Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis
Vasiliy I. Reshetnyak, Igor V. Maev
Biomedicines.2022; 10(12): 3046. CrossRef Low vitamin D concentrations and BMI are causal factors for primary biliary cholangitis: A mendelian randomization study
Honglin Xu, Ziyan Wu, Futai Feng, Yongzhe Li, Shulan Zhang
Frontiers in Immunology.2022;[Epub] CrossRef The Gut-Liver Axis in Cholestatic Liver Diseases
Andreas Blesl, Vanessa Stadlbauer
Nutrients.2021; 13(3): 1018. CrossRef Clinical and serological prognostic markers in primary biliary cholangitis
Markus Wilhelmi
Clinical and Molecular Hepatology.2021; 27(2): 360. CrossRef
|